BIIB Price Targets and Analyst Ratings NASDAQ:BIIB
BIIB Forecast. What You Should Know.
BIIB Historical Ratings and Targets
About Biogen Inc.
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; ADUHELM for the treatment of Alzheimer's disease; IMRALDI, an ad... BIIB Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.